2021-07-05
								Laekna Therapeutics and Innovent enter a partnership agreement to co-develop combination therapy of afuresertib and sintilimab in clinical studies in China
																
																								
									
									
										Laekna Therapeutics and Innovent enter a partnership agreement to co-develop combination therapy of afuresertib and sintilimab in clinical studies in China
										More
									 
								 
																More